Overview
Changli Wang practices in Tianjin, China. Wang is highly rated in 5 conditions, according to our data. Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Squamous Cell Lung Carcinoma.
Their clinical research consists of co-authoring 137 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerWang isDistinguished. Learn about Lung Cancer.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Lung AdenocarcinomaWang isAdvanced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)
- Squamous Cell Lung Carcinoma
- Experienced
- EGFR Positive Lung CancerWang isExperienced. Learn about EGFR Positive Lung Cancer.
- Febrile NeutropeniaWang isExperienced. Learn about Febrile Neutropenia.
- Lung MetastasesWang isExperienced. Learn about Lung Metastases.
- Lung NodulesWang isExperienced. Learn about Lung Nodules.
- Small Cell Lung Cancer (SCLC)
- Thymic Epithelial TumorWang isExperienced. Learn about Thymic Epithelial Tumor.